Shopping Cart
Remove All
Your shopping cart is currently empty
Trastuzumab-MMAE-DXd
Copy Product Info
😃Good
Synonyms:
Catalog No. T9901A-2054 Copy Product Info
Purity: 95%
😃Good
Trastuzumab-MMAE-DXd is an ADC composed of an antibody targeting HER2, combined with Monomethyl auristatin E (MMAE) and deruxtecan (DXd), and is used in the research of breast cancer.
Trastuzumab-MMAE-DXd
Product information is being updated, if you want to purchase, please click the bulk custom button.
Add to Quotation
Batch Information
Select Batch
Purity:95%
Appearance:Liquid
Color:Transparent
Contact us for more batch information
Resource Download
Product Introduction
Bioactivity
Related Conjugates and Formulations
Antigen Details
Antibody Information
Storage & Solubility Information
| Description | Trastuzumab-MMAE-DXd is an ADC composed of an antibody targeting HER2, combined with Monomethyl auristatin E (MMAE) and deruxtecan (DXd), and is used in the research of breast cancer. |
| Reactivity | Human |
| Application | Functional assay |
| Endotoxin | <1.0 EU/mg |
| Conjucates | Antibody: Trastuzumab (T9912) Linker: Not confirmed Payload: MMAE; DXd |
| Gene ID | |
| Uniprot ID | |
| Target | HER2/ERBB2 |
| Isotype | Human IgG1 kappa-MMAE-DXd |
| Storage | Store at low temperature -20°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
Calculator
Dose Conversion
You can also refer to dose conversion for different animals. More Dose Conversion
Tech Support
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Keywords
Preview
Related Tags:
Generate Quote
Catalog No.: Cas No.:
Add
| Size | Quantity | Unit Price | Amount | Operation |
|---|
Generate Quote
- TOP
Feedback
Hello! How can I help you today? 
Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.